|
Quotes & Info
|
| PLL > SEC Filings for PLL > Form 8-K on 8-Jan-2009 | All Recent SEC Filings |
8-Jan-2009
Change in Directors or Principal Officers
• an amendment to the Employment Agreement dated September 12, 2005 with Roberto Perez, (the "Perez Agreement"), the Company's President of Life Sciences;
• an amendment to the Employment Agreement dated June 1, 2004 with Lisa McDermott (the "McDermott Agreement"), the Company's Chief Financial Officer and Treasurer.
The Krasnoff Agreement, the Perez Agreement and the McDermott Agreement are
referred to herein collectively as the "Agreements", and the amendments to those
agreements effective December 31, 2008 are referred to as the "Amendments."
Also pursuant to the approval of the Committee, the Company amended and
restated the Supplementary Pension Plan (the "SPP"), effective December 31,
2008.
The Company entered into the Amendments and amended and restated the SPP in
order to comply with the applicable provisions of Section 409A of the Internal
Revenue Code of 1986, as amended (the "Code"), and the Treasury Regulations
issued thereunder (collectively "Section 409A"). Section 409A imposes penalties
and additional tax on service providers (including employees and directors) if a
nonqualified deferred compensation arrangement does not comply with its
provisions, and requires plans to be in documentary compliance beginning on
January 1, 2009.
As required by Section 409A, the amended and restated SPP provides that the
monthly pension under the SPP, which is offset by any payments under the
Company's tax-qualified pension plan, begins to be offset by such payments at
the time that the monthly pension begins under the SPP. Formerly, the offset
began at the time that payments began under the tax-qualified pension plan.
The Amendments to the Agreements include changes directly required by
Section 409A such as providing consistency in time and form of payments upon
separation from service regardless of the reason for the separation. The
Amendments also include other changes which are indirect consequences of the
restrictions imposed by Section 409A. Such changes include deleting from the
Krasnoff Agreement a provision that may have allowed for Section 409A
noncompliant acceleration and deferral of compensation in the event of a change
in control (which provision was intended to avoid Mr. Krasnoff's exposure to
certain excise taxes), and replacing it with a provision requiring payment to
Mr. Krasnoff in the event that upon a change in control, due to benefits
provided or payments made by the Company, Mr. Krasnoff has an obligation to pay
an excise tax under Section 4999 of the Code. The amount of the payment shall be
an amount such that after payment of all taxes, including any interests and
penalties, Mr. Krasnoff will retain an amount equal to the taxes imposed. The
Company provided for the payment in order to provide incentives for
Mr. Krasnoff's performance and retention in the event of any future change in
control without possible concern for excise taxes.
In addition, the Amendments add non-solicitation and non-disparagement
covenants to the Agreements, and provide that any severance payments will be
contingent upon continuing compliance with those non-solicitation and
non-disparagement covenants as well as the non-compete covenants already
contained in the Agreements. Under the Amendments, severance payments are also
contingent on the applicable officer's execution of a general release of claims
against the Company. The Company added these conditions to severance payments in
order to protect the Company in the event that an officer separates from
service.
Finally, the Perez Amendment revises Mr. Perez's annual bonus structure so
that Mr. Perez's annual bonus is determined entirely under the Company Executive
Incentive Bonus Plan, rather than partially by reference to targets specific to
the performance of Pall Life Sciences. The Company determined to change
Mr. Perez's bonus structure in order to provide for parity among named executive
officers and promote teamwork in improving the economic performance of the
Company overall.
The foregoing descriptions of the Amendments and the amended and restated SPP
do not purport to be complete and are qualified in their entirety by reference
to the full text of the Amendments and the amended and restated SPP, which the
Company will file as exhibits to its Quarterly Report on Form 10-Q for the
quarterly period ended January 31, 2009.
|
|